Search - tctmd.com

Displaying 721 - 740 of 800

Sort: Relevancy | Date

News Daily News

Celecoxib Enhances DES Efficacy, But at Clinical Cost

March 15, 2012

News Daily News

Experts Give Their Picks for Most Important Developments of 2011

Jason Kahn

March 08, 2012

News Daily News

Procedural Complications Not to Blame for Death After PCI

March 06, 2012

News Industry News

Abbott's Absolute Pro® Vascular Self-Expanding Stent System Receives FDA Approval for Treatment of Iliac Artery Disease

March 06, 2012

News Daily News

PFO Closure Can Prevent Recurrent Cerebrovascular Events

Yael L. Maxwell

March 06, 2012

News Daily News

Renal Denervation Bonus: Improving LV Function

March 05, 2012

News Industry News

Boston Scientific Receives Industry's First FDA Approval for Drug-Eluting Coronary Stent Use in Heart Attack Patients

February 21, 2012

News Daily News

Younger Women with AMI Less Likely to Present with Chest Pain Than Men

Yael L. Maxwell

February 20, 2012

News Industry News

St. Jude Medical Initiates a Study to Evaluate the Economic Impact of FFR in Asia and Australia

February 14, 2012

News Industry News

Increased reimbursement of Self-Expanding drug-eluting stents in Germany now for all indications

February 07, 2012

News Industry News

STENTYS concludes clinical trial ahead of plan

January 31, 2012

News Industry News

Independent Data Safety Monitoring Board Recommends St. Jude Medical’s FAME II Clinical Trial Stop Enrollment Following Positive Interim Analysis

January 17, 2012

News Industry News

Boston Scientific Epic™ Stent Demonstrates Positive Clinical Outcomes in Orion Trial

January 15, 2012

News Daily News

Study Shines Spotlight on US Readmissions After STEMI

Yael L. Maxwell

January 04, 2012

News Industry News

Abbott Initiates Clinical Trial to Evaluate the Absorb™ Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent

December 07, 2011

News Industry News

Head-to-head comparison of two second generation drug-eluting coronary stents demonstrates non-inferiority

November 10, 2011

News Conference News

Embolic Protection Devices for TAVR Show Promise

November 09, 2011

News Industry News

CUMC Expert Raises Concerns about Heart Disease Trends

November 09, 2011

News Industry News

Risk of late stent thrombosis continues for up to seven years in patients with first generation drug-eluting stents; risk factors identified

November 08, 2011

News Industry News

PROMUS Element(TM) Platinum Chromium Stent Demonstrates Excellent Outcomes in Patients With Long Coronary Lesions

November 07, 2011

Advertisement

Celecoxib Enhances DES Efficacy, But at Clinical Cost

Experts Give Their Picks for Most Important Developments of 2011

Procedural Complications Not to Blame for Death After PCI

Abbott's Absolute Pro® Vascular Self-Expanding Stent System Receives FDA Approval for Treatment of Iliac Artery Disease

PFO Closure Can Prevent Recurrent Cerebrovascular Events

Renal Denervation Bonus: Improving LV Function

Boston Scientific Receives Industry's First FDA Approval for Drug-Eluting Coronary Stent Use in Heart Attack Patients

Younger Women with AMI Less Likely to Present with Chest Pain Than Men

St. Jude Medical Initiates a Study to Evaluate the Economic Impact of FFR in Asia and Australia

Increased reimbursement of Self-Expanding drug-eluting stents in Germany now for all indications

STENTYS concludes clinical trial ahead of plan

Independent Data Safety Monitoring Board Recommends St. Jude Medical’s FAME II Clinical Trial Stop Enrollment Following Positive Interim Analysis

Boston Scientific Epic™ Stent Demonstrates Positive Clinical Outcomes in Orion Trial

Study Shines Spotlight on US Readmissions After STEMI

Abbott Initiates Clinical Trial to Evaluate the Absorb™ Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent

Head-to-head comparison of two second generation drug-eluting coronary stents demonstrates non-inferiority

Embolic Protection Devices for TAVR Show Promise

CUMC Expert Raises Concerns about Heart Disease Trends

Risk of late stent thrombosis continues for up to seven years in patients with first generation drug-eluting stents; risk factors identified

PROMUS Element(TM) Platinum Chromium Stent Demonstrates Excellent Outcomes in Patients With Long Coronary Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content